欧洲肝脏研究学会临床实践指南：丙型肝炎病毒感染的管理 - Suppr

Suppr

超能文献

EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

出版信息

J Hepatol. 2014 Feb;60(2):392-420. doi: 10.1016/j.jhep.2013.11.003. Epub 2013 Dec 9.

DOI:10.1016/j.jhep.2013.11.003

PMID:24331294

Abstract

摘要

相似文献

EASL Clinical Practice Guidelines: management of hepatitis C virus infection.

J Hepatol. 2014 Feb;60(2):392-420. doi: 10.1016/j.jhep.2013.11.003. Epub 2013 Dec 9.

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.

J Hepatol. 2014 Jan;60(1):78-86. doi: 10.1016/j.jhep.2013.08.018. Epub 2013 Aug 29.

A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.

J Hepatol. 2013 Nov;59(5):926-33. doi: 10.1016/j.jhep.2013.06.019. Epub 2013 Jun 26.

Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patients.

Liver Int. 2015 Sep;35(9):2090-9. doi: 10.1111/liv.12799. Epub 2015 Feb 23.

Telaprevir can be successfully and safely used to treat older patients with genotype 1b chronic hepatitis C.

J Hepatol. 2013 Aug;59(2):205-12. doi: 10.1016/j.jhep.2013.03.020. Epub 2013 Mar 28.

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

J Hepatol. 2013 Sep;59(3):434-41. doi: 10.1016/j.jhep.2013.04.035. Epub 2013 May 10.

Triple therapy with boceprevir or telaprevir for prior HCV non-responders.

Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):455-62. doi: 10.1016/j.bpg.2012.09.003.

Boceprevir plus pegylated interferon/ribavirin to re-treat hepatitis C virus genotype 1 in HIV-HCV co-infected patients: final results of the Spanish BOC HIV-HCV Study.

Int J Infect Dis. 2016 Dec;53:46-51. doi: 10.1016/j.ijid.2016.10.028. Epub 2016 Nov 1.

Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score.

J Viral Hepat. 2014;21(9):e98-e107. doi: 10.1111/jvh.12237. Epub 2014 Feb 25.

Triple therapy with first generation HCV protease inhibitors: lead-in or no lead-in phase?

J Hepatol. 2013 Feb;58(2):391-4. doi: 10.1016/j.jhep.2012.09.023. Epub 2012 Oct 9.

引用本文的文献

Systemic inflammatory response markers improve the discrimination for prognostic model in hepatocellular carcinoma.

Hepatol Int. 2025 Mar 25. doi: 10.1007/s12072-025-10806-6.

Optimizing Hepatitis C Treatment Monitoring: Is Sustained Virologic Response at 4 Weeks Becoming the New Standard?

Microorganisms. 2024 Oct 10;12(10):2050. doi: 10.3390/microorganisms12102050.

Sexual behaviour and incidence of sexually transmitted infections among men who have sex with men (MSM) using daily and event-driven pre-exposure prophylaxis (PrEP): Four-year follow-up of the Amsterdam PrEP (AMPrEP) demonstration project cohort.

PLoS Med. 2024 May 8;21(5):e1004328. doi: 10.1371/journal.pmed.1004328. eCollection 2024 May.

Hepatitis C Epidemiology: Insights from a Comprehensive Cohort Study in ASST Melegnano and Martesana, Lombardia Region, Northern Italy.

Pathogens. 2024 Feb 28;13(3):215. doi: 10.3390/pathogens13030215.

The Clinical Courses and Prognosis of Cirrhotic Patients after First Acute Decompensation: Prospective Cohort Study.

Diagnostics (Basel). 2023 Dec 20;14(1):14. doi: 10.3390/diagnostics14010014.

Outcomes of direct-acting antivirals in patients with HCV decompensated cirrhosis: a systematic review and meta-analysis.

Front Med (Lausanne). 2023 Nov 29;10:1295857. doi: 10.3389/fmed.2023.1295857. eCollection 2023.

Impressive recompensation in transjugular intrahepatic portosystemic shunt-treated individuals with complications of decompensated cirrhosis based on Baveno VII criteria.

World J Gastroenterol. 2023 Oct 14;29(38):5383-5394. doi: 10.3748/wjg.v29.i38.5383.

IL-23/IL-17 Axis in Chronic Hepatitis C and Non-Alcoholic Steatohepatitis-New Insight into Immunohepatotoxicity of Different Chronic Liver Diseases.

Int J Mol Sci. 2023 Aug 5;24(15):12483. doi: 10.3390/ijms241512483.

Neuropsychiatric disorders in chronic hepatitis C patients after receiving interferon or direct-acting antivirals: a nationwide cohort study.

Front Pharmacol. 2023 Jul 19;14:1191843. doi: 10.3389/fphar.2023.1191843. eCollection 2023.

175 Years of Bilirubin Testing: Ready for Point-of-Care?

Adv Healthc Mater. 2023 Jul;12(18):e2203380. doi: 10.1002/adhm.202203380. Epub 2023 Apr 10.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验